trending Market Intelligence /marketintelligence/en/news-insights/trending/CUJhOvdfPMEleoR6SLhNrw2 content esgSubNav
In This List

Universal Biosensors to buyback shares

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Universal Biosensors to buyback shares

Universal Biosensors Inc. said its board had approved an on-market buyback of the company's shares.

The Australian medical diagnostics company said it will buyback up to 10% of its securities over the next year.

In other news, the company has also decided on the terms of an agreement to distribute Siemens AG's blood clotting products.

The deal will allow Universal Biosensors to have increased control over the pricing of analyzers and strips. Moreover, Siemens will give Universal Biosensors access to its proprietary substances necessary for strip manufacturing.

Universal Biosensors will pay Siemens $12.5 million, of which $11 million is payable within five days once an agreement is signed.